Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Red Blood Cells with ACD-A Anticoagulant and AS-3 Additive Produced through Apheresis Using the Trima Accel - Study
Principal Investigator
Study Number
STUDY02002684
Phase
I
Available at the following location(s)
- Lebanon
Do you need help with some of the labels on this page?
Read our glossary of terms